Plain-English translation of NCT05984576 on ClinicalTrials.gov ↗ · Source last updated · Translation generated ·
This is an observational study that tracks patients with recurrent rectal cancer—cancer that has returned after initial treatment—who receive radiation therapy combined with chemotherapy. The study is designed to understand how effective this combined approach is for people who have previously received radiation, and to learn the best ways to deliver these treatments safely while minimizing side effects.
Rectal cancer that comes back is challenging to treat, especially if patients have already received radiation. This study exists to gather real-world information about how radiation combined with chemotherapy works in this difficult situation, and to help doctors figure out which patients benefit most from different treatment approaches.
You likely qualify if…
You likely don't qualify if…
As a participant, you would receive radiation therapy combined with chemotherapy as part of your standard cancer treatment. The study team will closely monitor your response to treatment using imaging scans and blood tests, track any side effects, and follow your progress over time. Your previous radiation treatment records will be reviewed to ensure your new treatment is planned safely, taking into account the dose you previously received.
AI-generated summary from trial data · Aug 11, 2026 · Not medical advice
Italy